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Melanomas derived from the pigmented uveal tract of 




Choroid melanomas are the commonest (60-70%), and 
iris melanomas are particulary rare (5-8%). 
Clinics and pathology 
Embryonic origin 
Neuroectodermal cell lineage. 
Epidemiology 
Annual incidence in the USA of 5-7 million population 
annually, similarities to cutaneous melanoma as the 
incidence is higher amongst fair skinned pale eyed 
individuals; median age for presentation 55 years, and a 
slightly higher incidence for males; the aetiology is 
unclear, but possibly sun exposure is a risk factor. 
Clinics 
Obscured vision symptons of a retinal detachment, 
cataract formation, and occasionally painful eye. 
Pathology 
Classified into three categories depending on cell type; 
spindle cell melanoma has the best prognosis, 
epithelioid is most likey to spread, whilst mixed cell 
melanomas have an intermediate behaviour; (of note, 
the size and position of the tumour also affects the 
prognosis of individual melanomas); uveal melanomas 
can invade locally within the eye, and form deposits in 
other organs, but most commonly the liver. 
Treatment 
Local resection, enucleation, photocoagulation, 
external beam irradiation, brachytherapy, and laser 
therapy. 
Evolution 
Metastasis occurs, mainly to the liver, with 
approximately half of patients treated with enucleation 
dying within ten to fifteen years; the highest rates of 
metastasis ocurr in the first five years, but have been 
recorded over forty years after the primary tumour was 
detected. 
Prognosis 
Spindle cell tumours, and those less than 10 mm in 
diameter have the best outcome; ciliary body 
melanomas and those where there is scleral invasion 
have a worse prognosis. 
Cytogenetics 
Cytogenetics Morphological 
Most analysis performed on ciliary body and choroid 
melanomas; usually relatively simple chromosome 
alterations, often with diploid karyotypes; the 
commonest alterations are those of chromosomes 1, 3, 
6, 8 and the Y chromosome; monosomy 3 and 
isochromosome 8q occur in association in ciliary body 
melanomas, and are both independently predictive of 
poor prognosis, with the increase in the copy number of 
8q also indicative of the disease free interval; 
chromosome 1 changes have been linked with large 
aggressive tumours and abnormalities of chromosome 6 
are suggested to indicate a better prognosis. 
Cytogenetics Molecular 
Studies are not as comprehensive as cytogenetic 
studies; comparative genomic hybridization has mainly  
confirmed cytogenetic data, but also identified les  
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frequent alterations including those of chromsome 9p; 
no specific genes implicated, p16, p53, BRCA 2 have 
been investigated but appear to be involved in only a 
small percentage of tumours; studies suggest that genes 
on chromosome 3 play a role, and several regions have 
been implicated; no association between MYCand poor 
prognosis has been made, and flow cytomeric analysis 
suggests that DNA index is not a reliable predictor of 
prognosis. 
References 
Horsthemke B, Prescher G, Bornfeld N, Becher R. Loss of 
chromosome 3 alleles and multiplication of chromosome 8 
alleles in uveal melanoma. Genes Chromosomes Cancer 
1992;4(3):217-221 
Prescher G, Bornfeld N, Friedrichs W, Seeber S, Becher R. 
Cytogenetics of twelve cases of uveal melanoma and patterns 
of nonrandom anomalies and isochromosome formation. 
Cancer Genet Cytogenet 1995;80(1):40-46 
Sisley K, Rennie IG, Parsons MA, Jacques R, Hammond DW, 
Bell SM, Potter AM, Rees RC. Abnormalities of chromosomes 
3 and 8 in posterior uveal melanoma correlate with prognosis. 
Genes Chromosomes Cancer 1997;19(1):22-28 
Sisley K, Cottam DW, Rennie IG, Parsons MA, Potter AM, 
Potter CW, Rees RC. Non-random abnormalities of 
chromosomes 3, 6, and 8 associated with posterior uveal 
melanoma. Genes Chromosomes Cancer 1992 Oct;5(3):197-
200 
Sisley K, Curtis D, Rennie IG, Rees RC. Loss of heterozygosity 
of the thyroid hormone receptor B in posterior uveal 
melanoma. Melanoma Res 1993 Dec;3(6):457-61 
Sisley K, Brand C, Parsons MA, Maltby E, Rees RC, Rennie 
IG. Cytogenetics of iris melanomas: disparity with other uveal 
tract melanomas. Cancer Genet Cytogenet 1998 
Mar;101(2):128-33 
Sisley K, Nichols C, Parsons MA, Farr R, Rees RC, Rennie IG. 
Clinical applications of chromosome analysis, from fine needle 
aspiration biopsies, of posterior uveal melanomas. Eye 
1998;12 ( Pt 2):203-7 
White VA, Chambers JD, Courtright PD, Chang WY, Horsman 
DE. Correlation of cytogenetic abnormalities with the outcome 
of patients with uveal melanoma. Cancer 1998 Jul 
15;83(2):354-9 
White VA, McNeil BK, Horsman DE. Acquired homozygosity 
(isodisomy) of chromosome 3 in uveal melanoma. Cancer 
Genet Cytogenet 1998 Apr 1;102(1):40-5 
Singh AD, Boghosian-Sell L, Wary KK, Shields CL, De Potter 
P, Donoso LA, Shields JA, Cannizzaro LA. Cytogenetic 
findings in primary uveal melanoma. Cancer Genet Cytogenet 
1994 Feb;72(2):109-15 
Speicher MR, Prescher G, du Manoir S, Jauch A, Horsthemke 
B, Bornfeld N, Becher R, Cremer T. Chromosomal gains and 
losses in uveal melanomas detected by comparative genomic 
hybridization. Cancer Res 1994 Jul 15;54(14):3817-23 
Mooy CM, De Jong PT. Prognostic parameters in uveal 
melanoma: a review. Surv Ophthalmol 1996 Nov-
Dec;41(3):215-28. (Review) 
Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jöckel KH, 
Becher R. Prognostic implications of monosomy 3 in uveal 
melanoma. Lancet 1996 May 4;347(9010):1222-5 
Richardson RP, Lawry L, Rees RC, Rennie IG. DNA index and 
% S phase fraction in posterior uveal melanoma: a 5 year 
prospective study of fresh tissue using flow cytometry. Eye 
1997;11 ( Pt 5):629-34 
Chana JS, Cree IA, Foss AJ, Hungerford JL, Wilson GD. The 
prognostic significance of c-myc oncogene expression in uveal 
melanoma. Melanoma Res 1998 Apr;8(2):139-44 
This article should be referenced as such: 
Sisley K. Head and neck: Posterior uveal melanoma. Atlas 
Genet Cytogenet Oncol Haematol. 1999; 3(3):160-161. 
